ATE372777T1 - Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen - Google Patents
Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungenInfo
- Publication number
- ATE372777T1 ATE372777T1 AT04777982T AT04777982T ATE372777T1 AT E372777 T1 ATE372777 T1 AT E372777T1 AT 04777982 T AT04777982 T AT 04777982T AT 04777982 T AT04777982 T AT 04777982T AT E372777 T1 ATE372777 T1 AT E372777T1
- Authority
- AT
- Austria
- Prior art keywords
- nitrite
- tissues
- administration
- subject
- reperfusion injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48595903P | 2003-07-09 | 2003-07-09 | |
US51124403P | 2003-10-14 | 2003-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE372777T1 true ATE372777T1 (de) | 2007-09-15 |
Family
ID=34068230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04777982T ATE372777T1 (de) | 2003-07-09 | 2004-07-09 | Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen |
Country Status (9)
Country | Link |
---|---|
US (5) | US9675637B2 (de) |
EP (2) | EP1653978B1 (de) |
JP (3) | JP5564157B2 (de) |
AT (1) | ATE372777T1 (de) |
AU (2) | AU2004257693B8 (de) |
CA (2) | CA2536827C (de) |
DE (1) | DE602004008927T2 (de) |
ES (1) | ES2294543T3 (de) |
WO (2) | WO2005007173A1 (de) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8133698B2 (en) * | 2000-05-15 | 2012-03-13 | Silver James H | Sensors for detecting substances indicative of stroke, ischemia, infection or inflammation |
EP3064242A1 (de) | 2003-04-28 | 2016-09-07 | Advanced Circulatory Systems Inc. | Lüfter und verfahren zur behandlung von kopftrauma und geringer blutzirkulation |
EP1653978B1 (de) | 2003-07-09 | 2020-06-03 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Vervendung von nitritsalzen zur behandlung von cardiovaskulären erkrankungen |
US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
WO2006113540A2 (en) | 2005-04-14 | 2006-10-26 | Duke University | Use of ntrosylated hemoglobin |
US8557300B2 (en) | 2005-05-19 | 2013-10-15 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
EP2099463B1 (de) * | 2006-11-07 | 2014-07-16 | The General Hospital Corporation | Minderung von vasoaktiver sauerstoffträger-induzierter gefässverengung |
US10821132B2 (en) | 2007-02-26 | 2020-11-03 | Heartbeet Ltd | Compositions of nitrates and methods of use thereof |
US11759477B2 (en) | 2007-02-26 | 2023-09-19 | Heartbeet Ltd. | Compositions of nitrates and methods of use thereof |
EP2114417A4 (de) * | 2007-02-26 | 2014-04-02 | Heartbeet Ltd | Neue verwendung von nitriten, nitraten und zusammensetzungen damit |
US10842813B2 (en) | 2007-02-26 | 2020-11-24 | Heartbeet Ltd | Compositions of nitrates and methods of use thereof |
US10835555B2 (en) | 2007-02-26 | 2020-11-17 | Heartbeet Ltd | Compositions of nitrates and methods of use thereof |
JP2010519335A (ja) | 2007-02-26 | 2010-06-03 | ルンドベルク,ヨン | 運動能力向上組成物及びその使用 |
US9352111B2 (en) | 2007-04-19 | 2016-05-31 | Advanced Circulatory Systems, Inc. | Systems and methods to increase survival with favorable neurological function after cardiac arrest |
WO2009035550A1 (en) * | 2007-09-10 | 2009-03-19 | Duke University | Treating patients with subarachnoid hemorrhage |
US10426750B1 (en) | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid supplement formulations |
US8455531B2 (en) | 2007-09-18 | 2013-06-04 | Thermolife International, Llc | Amino acid compositions |
US10646508B1 (en) | 2007-09-18 | 2020-05-12 | Thermolife International, Llc | Method of safely administering nitrate dietary supplements and compositions |
US10426792B1 (en) | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid compositions |
US8569368B2 (en) | 2007-09-18 | 2013-10-29 | Thermolife International, Llc | Amino acid compounds |
US8569369B2 (en) | 2007-09-18 | 2013-10-29 | Thermolife International, Llc | Amino acid compounds |
US10435356B1 (en) | 2007-09-18 | 2019-10-08 | Thermolife International, Llc | Amino acid compositions |
US7777074B2 (en) | 2007-09-18 | 2010-08-17 | Thermolife International, Llc | Amino acid compounds |
US8466187B2 (en) | 2007-09-18 | 2013-06-18 | Thermolife International, Llc | Amino acid compositions |
WO2009038796A1 (en) * | 2007-09-20 | 2009-03-26 | Wake Forest University Health Sciences | Methods of treatment for hemolysis |
WO2009065142A2 (en) * | 2007-11-15 | 2009-05-22 | Biomedical Research Foundation Of Northwest Louisiana | Use of nitrite salts in chronic ischemia |
WO2009086470A2 (en) * | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
WO2009108777A2 (en) * | 2008-02-28 | 2009-09-03 | The Uab Research Foundation | Use of nitrite to enhance viability, recovery, and function of transplant specimens |
US20100016731A1 (en) * | 2008-07-15 | 2010-01-21 | Cardiox Corporation | Hemodynamic Detection of Circulatory Anomalies |
WO2010035253A1 (en) * | 2008-09-28 | 2010-04-01 | Joshua Waldhorn | Effective nitric oxide generating preparations |
AU2016204616B2 (en) * | 2009-02-11 | 2017-05-11 | Hope Medical Enterprise, Inc. D.B.A. Hope Pharmaceuticals | Sodium nitrite-containing pharmaceutical compositions |
AU2015202300B2 (en) * | 2009-02-11 | 2016-05-26 | Hope Medical Enterprise, Inc. D.B.A. Hope Pharmaceuticals | Sodium nitrite-containing pharmaceutical compositions |
US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
US9114109B2 (en) | 2009-06-16 | 2015-08-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | Five-coordinate neuroglobin and use thereof as a blood substitute |
US20120237617A1 (en) * | 2009-06-18 | 2012-09-20 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
WO2010151150A2 (en) * | 2009-06-22 | 2010-12-29 | Charles Eason | Formulations for vertebrate pest control |
AU2009202685B1 (en) | 2009-06-30 | 2010-08-19 | Ino Therapeutics Llc | Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
PT2451435T (pt) | 2009-07-08 | 2018-01-15 | Hope Medical Entpr Inc D B A Hope Pharmaceuticals | Composições farmacêuticas que contêm tiossulfato de sódio |
US8273857B2 (en) * | 2009-09-22 | 2012-09-25 | Jen-Chang Hsia | Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine |
US20130209584A1 (en) * | 2009-10-14 | 2013-08-15 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
CN102686111A (zh) | 2009-10-14 | 2012-09-19 | 瑟阿瓦斯克有限公司 | 亚硝酸盐/酯的药物制剂以及其应用 |
WO2012135623A1 (en) * | 2011-03-31 | 2012-10-04 | Theravasc Inc. | Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline |
EP2696865B1 (de) | 2011-04-13 | 2016-12-21 | Thermolife International, LLC | Verwendungsverfahren für n-acetyl-beta-alanin |
GB201114901D0 (en) | 2011-08-26 | 2011-10-12 | King S College London | Vascular treatments |
WO2013052803A2 (en) * | 2011-10-07 | 2013-04-11 | Radiorx, Inc. | Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products |
AU2012319071B2 (en) | 2011-10-07 | 2017-08-03 | Epicentrx, Inc. | Organonitro thioether compounds and medical uses thereof |
WO2013070592A1 (en) | 2011-11-07 | 2013-05-16 | The General Hospital Corporation | Treatment of red blood cells |
AU2012358977A1 (en) | 2011-12-19 | 2014-07-24 | ResQSystems, Inc. | Systems and methods for therapeutic intrathoracic pressure regulation |
US20140066881A1 (en) * | 2012-08-31 | 2014-03-06 | Zoll Medical Corporation | Cardiac resuscitation methods and kits |
JP6441818B2 (ja) * | 2013-02-07 | 2018-12-19 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 心不全の治療法 |
EP2958573B1 (de) | 2013-02-20 | 2019-05-08 | The Board of Supervisors of the Louisiana State University Mechanical and Agricultural College | Pharmazeutische formulierungen aus nitrit und verwendungen davon |
US20160008394A1 (en) * | 2013-02-28 | 2016-01-14 | Aires Pharmaceuticals, Inc. | Inorganic nitrite to improve cardiopulmonary hemodynamics |
US10517817B2 (en) * | 2013-05-09 | 2019-12-31 | Syk Technologies, Llc | Deep topical systemic nitric oxide therapy apparatus and method |
US10265495B2 (en) | 2013-11-22 | 2019-04-23 | Zoll Medical Corporation | Pressure actuated valve systems and methods |
CN104096218B (zh) * | 2014-06-05 | 2017-03-22 | 董文其 | 重组人源细胞珠蛋白在制备治疗高血脂症及动脉粥样硬化药物中的应用 |
WO2016077386A1 (en) | 2014-11-10 | 2016-05-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Topical sodium nitrite formulation |
US10342778B1 (en) | 2015-10-20 | 2019-07-09 | Epicentrx, Inc. | Treatment of brain metastases using organonitro compound combination therapy |
US9987270B1 (en) | 2015-10-29 | 2018-06-05 | Epicentrix, Inc. | Treatment of gliomas using organonitro compound combination therapy |
ES2880482T3 (es) | 2016-01-11 | 2021-11-24 | Epicentrx Inc | Composiciones y métodos para la administración intravenosa de 2-bromo-1-(3,3-dinitroazetidin-1-il)etanona |
GB201602959D0 (en) | 2016-02-19 | 2016-04-06 | Isis Innovation | Use of cerebral nitric oxide donors in the assessment of the extent of brain dyfunction following injury |
ES2651717B1 (es) * | 2016-07-26 | 2018-11-16 | Lara OLLER DUQUE | Solución acuosa cristaloide isotónica |
JP7332469B2 (ja) | 2016-10-14 | 2023-08-23 | エピセントアールエックス,インコーポレイテッド | スルホキシアルキル有機窒素および関連のある化合物ならびに医学における使用のための医薬組成物 |
US10624921B2 (en) | 2016-11-15 | 2020-04-21 | Berkeley Nox Limited | Dietary supplements |
CA3047041A1 (en) * | 2016-12-12 | 2018-06-21 | Aobiome Llc | Ammonia oxidizing microorganisms for the regulation of blood pressure |
WO2018132371A2 (en) | 2017-01-10 | 2018-07-19 | United Therapeutics Corporation | Methods and compositions for treating pulmonary hypertension |
US11116731B2 (en) | 2017-02-20 | 2021-09-14 | Brd. of Sup. of LSU and A &M College | Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation |
IL295119B2 (en) | 2017-03-08 | 2023-10-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
IL312092A (en) | 2017-03-08 | 2024-06-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium nitrite |
CA3069004A1 (en) | 2017-07-07 | 2019-01-10 | Epicentrx, Inc. | Compositions for parenteral administration of therapeutic agents |
WO2019099003A2 (en) * | 2017-11-15 | 2019-05-23 | Berkeley Nox Limited | Novel dietary supplements |
WO2019164593A2 (en) | 2018-01-08 | 2019-08-29 | Epicentrx, Inc. | Methods and compositions utilizing rrx-001 combination therapy for radioprotection |
JP7469816B2 (ja) * | 2019-07-22 | 2024-04-17 | 学校法人北里研究所 | 透析装置 |
WO2021046456A2 (en) * | 2019-09-05 | 2021-03-11 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Nitrite formulations and uses thereof for the treatment of lung injury |
US11865139B2 (en) | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
Family Cites Families (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3865942A (en) | 1971-04-28 | 1975-02-11 | Rech Applic Scient Sogeras 424 | Method of increasing cerebral blood flow |
GB1595056A (en) | 1976-10-12 | 1981-08-05 | Wellcome Found | Pharmaceutical combination |
US4163790A (en) | 1977-05-11 | 1979-08-07 | A. H. Robins Company, Inc. | Method for increasing coronary blood flow in mammals |
US4849226A (en) | 1981-06-29 | 1989-07-18 | Alza Corporation | Method for increasing oxygen supply by administering vasodilator |
US4650484A (en) | 1983-02-03 | 1987-03-17 | Alza Corporation | Method for treating ischemic conditions |
US5500230A (en) | 1987-01-23 | 1996-03-19 | The General Hospital Corporation | Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators |
JPH0753358Y2 (ja) | 1988-04-08 | 1995-12-06 | 株式会社ケンウッド | 音響機器の制御回路 |
US5683668A (en) | 1990-09-20 | 1997-11-04 | The United States Of America As Represented By The Department Of Health And Human Services | Method of generating nitric oxide gas using nitric oxide complexes |
US5263473A (en) | 1990-11-05 | 1993-11-23 | The Kendall Company | Compression device for the limb |
US5570683A (en) | 1990-12-05 | 1996-11-05 | The General Hospital Corporation | Methods and devices for treating pulmonary vasoconstriction and asthma |
EP1516639B2 (de) | 1990-12-05 | 2015-04-15 | The General Hospital Corporation | Verwendung von NO zur Behandlung der persistenten pulmonaren Hypertonie des Neugeborenen |
US5396882A (en) | 1992-03-11 | 1995-03-14 | The General Hospital Corporation | Generation of nitric oxide from air for medical uses |
US5536241A (en) | 1990-12-05 | 1996-07-16 | The General Hospital Corporation | Methods and devices for relaxing smooth muscle contractions |
US5108754A (en) | 1991-02-08 | 1992-04-28 | Michael Wilburn | Orthomolecular method of treating sickle cell disease |
US5177208A (en) | 1991-02-08 | 1993-01-05 | Michael Wilburn | Orthomolecular method of treating sickle cell disease |
US5273875A (en) * | 1991-03-22 | 1993-12-28 | Cornell Research Foundation, Inc. | N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
JP3190340B2 (ja) | 1991-09-24 | 2001-07-23 | アメリカ合衆国 | 酸化窒素供与体プロドラッグとしての求核試薬−酸化窒素付加物の酸素置換誘導体 |
US6291424B1 (en) | 1991-11-14 | 2001-09-18 | Brigham And Women's Hospital | Nitrosated and nitrosylated heme proteins |
US6187744B1 (en) | 1992-03-11 | 2001-02-13 | Michael W. Rooney | Methods and compositions for regulating the intravascular flow and oxygenating activity of hemoglobin in a human or animal subject |
US5389675A (en) | 1992-03-27 | 1995-02-14 | The United States Of America As Represented By The Department Of Health And Human Services | Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
US5814666A (en) | 1992-04-13 | 1998-09-29 | The United States As Represented By The Department Of Health And Human Services | Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
US5525357A (en) | 1992-08-24 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US5405919A (en) * | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US5385940A (en) | 1992-11-05 | 1995-01-31 | The General Hospital Corporation | Treatment of stroke with nitric-oxide releasing compounds |
US5427797A (en) | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
JPH0753358A (ja) | 1993-08-17 | 1995-02-28 | Teijin Ltd | 吸入剤 |
US6087479A (en) | 1993-09-17 | 2000-07-11 | Nitromed, Inc. | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US5728705A (en) | 1993-10-04 | 1998-03-17 | The Trustees Of Columbia University In The City Of New York | Method of inducing vasorelaxation to treat pulmonary hypertension |
US5840759A (en) | 1993-10-08 | 1998-11-24 | The United States Of America As Represented By The Department Of Health And Human Services | Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents |
ATE194769T1 (de) | 1993-10-08 | 2000-08-15 | Us Health | Verwendung von stickstoffoxid freisetzenden verbindungen als arzneimittel zur strahlungssensibilisation fur hypoxische zellen |
GB9320978D0 (en) | 1993-10-12 | 1993-12-01 | Higenbottam Timohy W | Nitric oxide treatment |
JPH09508097A (ja) * | 1993-11-02 | 1997-08-19 | アメリカ合衆国 | 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用 |
GB9804469D0 (en) | 1998-03-02 | 1998-04-29 | Univ Aberdeen | Antiviral composition |
US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
WO1995022335A1 (en) | 1994-02-21 | 1995-08-24 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
US5648101A (en) | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
US6063407A (en) | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
AU5368296A (en) | 1995-03-24 | 1996-10-16 | Brigham And Women's Hospital | Nitrosylated blood substitutes |
US5823180A (en) | 1995-04-03 | 1998-10-20 | The General Hospital Corporation | Methods for treating pulmonary vasoconstriction and asthma |
US6627738B2 (en) | 1995-09-15 | 2003-09-30 | Duke University | No-modified hemoglobins and uses therefor |
US6153186A (en) * | 1995-09-15 | 2000-11-28 | Duke University Medical Center | Red blood cells loaded with S-nitrosothiol and uses therefor |
US6197745B1 (en) | 1995-09-15 | 2001-03-06 | Duke University | Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
US6258032B1 (en) | 1997-01-29 | 2001-07-10 | William M. Hammesfahr | Method of diagnosis and treatment and related compositions and apparatus |
US5824669A (en) | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
PT914103E (pt) | 1996-04-05 | 2006-09-29 | Gen Hospital Corp | Tratamento de uma hemoglobinopatia |
US5770645A (en) | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US6057367A (en) | 1996-08-30 | 2000-05-02 | Duke University | Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses |
US5958427A (en) | 1996-11-08 | 1999-09-28 | Salzman; Andrew L. | Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
US5912019A (en) | 1997-02-07 | 1999-06-15 | Musc Foundation For Research Development | Compounds for reducing ischemia/reperfusion injury |
BR9811473A (pt) | 1997-07-11 | 2001-12-26 | Univ Johns Hopkins Med | Infecção por rinovìrus inibida por óxido nìtrico |
US6796966B2 (en) | 1997-10-15 | 2004-09-28 | Jeffrey E. Thomas | Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal |
US6358536B1 (en) | 1997-10-15 | 2002-03-19 | Thomas Jefferson University | Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
US5994444A (en) | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
US6656452B1 (en) | 1997-10-21 | 2003-12-02 | The General Hospital Corporation | Use of inhaled NO as anti-inflammatory agent |
ATE277038T1 (de) | 1997-12-23 | 2004-10-15 | Amersham Health As | Stickstoffoxid freisetzende chelatbildner und ihre therapeutische verwendung |
AU2479099A (en) | 1998-01-28 | 1999-08-16 | Seatrace Pharmaceuticals, Inc. | Topical vasodilatory gel composition and methods of use and production |
US6103275A (en) * | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
US20070086954A1 (en) | 1998-11-23 | 2007-04-19 | Miller Christopher C | Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
CA2254645A1 (en) | 1998-11-23 | 2000-05-23 | Pulmonox Medical Corporation | Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
US20050142218A1 (en) | 2000-03-09 | 2005-06-30 | Queen Mary & Westfield College | Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
WO2000056863A1 (en) | 1999-03-19 | 2000-09-28 | Agritope, Inc. | Banana and melon promoters for expression of transgenes in plants |
US6187332B1 (en) | 1999-06-14 | 2001-02-13 | Wisconsin Alumni Research Foundation | Acidic buffered nasal spray |
CA2680378C (en) | 1999-08-02 | 2013-09-24 | Duke University | Method for determining physiological effects of hemoglobin |
JP2003506394A (ja) | 1999-08-10 | 2003-02-18 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム | 視力の保持を容易にするために視神経、脈絡膜、および網膜の血流を増大させるための方法 |
US6314956B1 (en) | 1999-09-08 | 2001-11-13 | Duke University | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders |
CA2323008C (en) | 1999-10-11 | 2005-07-12 | Pfizer Inc. | Pharmaceutically active compounds |
US6612306B1 (en) | 1999-10-13 | 2003-09-02 | Healthetech, Inc. | Respiratory nitric oxide meter |
DE19960404A1 (de) | 1999-12-15 | 2001-07-05 | Messer Austria Gmbh Gumpoldski | Exspirationsabhängige Gasdosierung |
US6476037B1 (en) | 2000-03-23 | 2002-11-05 | The Regents Of The University Of California | L-arginine and phosphodiesterase (PDE) inhibitor synergism |
ES2232613T3 (es) | 2000-04-26 | 2005-06-01 | Cellegy Pharmaceuticals, Inc | Formulaciones y metodos de utilizacion de agentes mimeticos del oxido nitrico contra un fenotipo celular maligno. |
DE10025202A1 (de) | 2000-05-20 | 2001-11-29 | Messer Austria Gmbh Gumpoldski | Gasdosiergerät mit Katheter |
JP4181290B2 (ja) | 2000-06-12 | 2008-11-12 | 学校法人早稲田大学 | ヘモグロビン小胞体の光還元法 |
US6601580B1 (en) | 2000-06-28 | 2003-08-05 | The General Hospital Corporation | Enhancing therapeutic effectiveness of nitric oxide inhalation |
GB0021317D0 (en) | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
AU8852301A (en) | 2000-09-01 | 2002-03-13 | Meir S Sacks | Compositions and methods for inducing vasorelaxation |
GB0022084D0 (en) | 2000-09-08 | 2000-10-25 | Univ Aberdeen | Treatment of multiply antibiotic-resistant organisms |
ATE462424T1 (de) | 2000-10-16 | 2010-04-15 | Univ Duke | Therapeutische anwendung von zerstäubtem s- nitrosoglutathion bei zystischer fibrose |
CA2421885A1 (en) | 2000-10-27 | 2002-05-02 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US7335181B2 (en) | 2000-12-26 | 2008-02-26 | Pulmonox Technologies Corporation | Nitric oxide decontamination of the upper respiratory tract |
JP4430867B2 (ja) | 2001-01-16 | 2010-03-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 基材/血液境界面で、insituで、生体触媒により生じる、生体疑似的な(biomimetic)一酸化窒素の生成 |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US6676855B2 (en) | 2001-08-02 | 2004-01-13 | Duke University | Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
US7025869B2 (en) | 2001-09-05 | 2006-04-11 | Cyterra Corporation | Nitric oxide delivery system |
GB0125222D0 (en) | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
US6472390B1 (en) | 2001-11-13 | 2002-10-29 | Duke University | Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
US20050164915A1 (en) | 2002-04-01 | 2005-07-28 | Sangart, Inc. | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
EP1336602A1 (de) | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrat-Prodrugs zur Freisetzung von Stickstoffmonoxid in kontrollierter und selektiver Weise sowie deren Verwendung zur Prävention und Behandlung inflammatorischer, ischämischer und proliferativer Erkrankungen |
US20030203915A1 (en) | 2002-04-05 | 2003-10-30 | Xinqin Fang | Nitric oxide donors, compositions and methods of use related applications |
JP2005527834A (ja) | 2002-05-29 | 2005-09-15 | デューク・ユニバーシティー | 血液ガス中の一酸化窒素の測定およびそれに基づく処置 |
US7241350B2 (en) * | 2002-12-03 | 2007-07-10 | Greenkote (Israel) Ltd. | Corrosion resistant poly-metal diffusion coatings and a method of applying same |
CA2509817C (en) | 2002-12-12 | 2014-11-04 | Duke University | Forming iron nitrosyl hemoglobin |
SE0300971D0 (sv) | 2003-04-03 | 2003-04-03 | Aga Ab | Nitric oxide in treatment of inflammation |
EP1653978B1 (de) * | 2003-07-09 | 2020-06-03 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Vervendung von nitritsalzen zur behandlung von cardiovaskulären erkrankungen |
US7329641B2 (en) | 2003-10-30 | 2008-02-12 | Temple University Of The Commonwealth System Of Higher Education | Blood substitutes |
AU2005244078A1 (en) | 2004-05-11 | 2005-11-24 | Pulmonox Technologies Corporation | Intermittent dosing of nitric oxide gas |
US7362274B1 (en) | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
US20060088583A1 (en) | 2004-10-25 | 2006-04-27 | Oxygenix Co., Ltd. | Artificial oxygen carrier containing preventive agents of metHb formation |
EP1863503B1 (de) | 2005-03-07 | 2019-05-22 | Sangart, Inc. | Zusammensetzung zur abgabe von kohlenmonoxid (co) und stickoxid (no) an gewebe unter verwendung von heme-proteinen als träger |
WO2006113540A2 (en) | 2005-04-14 | 2006-10-26 | Duke University | Use of ntrosylated hemoglobin |
US7604291B2 (en) * | 2005-04-20 | 2009-10-20 | Vitito Christopher J | Vehicle entertainment system incorporated within the armrest/console of a vehicle with a swivel monitor mounting structure |
US8790715B2 (en) | 2006-02-16 | 2014-07-29 | Ino Therapeutics Llc | Method and apparatus for generating nitric oxide for medical use |
EP2076537B1 (de) | 2006-10-06 | 2018-08-22 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Prävention von gewebeischämie, damit in zusammenhang stehende verfahren und zusammensetzungen |
US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
US20160008394A1 (en) | 2013-02-28 | 2016-01-14 | Aires Pharmaceuticals, Inc. | Inorganic nitrite to improve cardiopulmonary hemodynamics |
-
2004
- 2004-07-09 EP EP04756810.0A patent/EP1653978B1/de not_active Expired - Lifetime
- 2004-07-09 EP EP04777982A patent/EP1648475B1/de not_active Expired - Lifetime
- 2004-07-09 AT AT04777982T patent/ATE372777T1/de active
- 2004-07-09 WO PCT/US2004/021985 patent/WO2005007173A1/en active Search and Examination
- 2004-07-09 CA CA 2536827 patent/CA2536827C/en not_active Expired - Lifetime
- 2004-07-09 JP JP2006518922A patent/JP5564157B2/ja not_active Expired - Lifetime
- 2004-07-09 WO PCT/US2004/022232 patent/WO2005004884A2/en active IP Right Grant
- 2004-07-09 DE DE200460008927 patent/DE602004008927T2/de not_active Expired - Lifetime
- 2004-07-09 CA CA 2537222 patent/CA2537222A1/en not_active Abandoned
- 2004-07-09 US US10/563,683 patent/US9675637B2/en active Active
- 2004-07-09 JP JP2006518959A patent/JP5564158B2/ja not_active Expired - Lifetime
- 2004-07-09 AU AU2004257693A patent/AU2004257693B8/en not_active Expired
- 2004-07-09 AU AU2004255268A patent/AU2004255268B2/en not_active Expired
- 2004-07-09 ES ES04777982T patent/ES2294543T3/es not_active Expired - Lifetime
-
2010
- 2010-03-26 US US12/748,184 patent/US8927030B2/en active Active
-
2011
- 2011-12-22 JP JP2011280763A patent/JP2012092129A/ja active Pending
-
2012
- 2012-02-28 US US13/407,118 patent/US9387224B2/en active Active
-
2015
- 2015-01-05 US US14/589,324 patent/US9700578B2/en not_active Expired - Lifetime
-
2017
- 2017-06-22 US US15/630,017 patent/US20170281673A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004257693B8 (en) | 2009-08-13 |
JP2007528852A (ja) | 2007-10-18 |
WO2005004884A3 (en) | 2005-04-21 |
CA2537222A1 (en) | 2005-01-27 |
EP1648475A2 (de) | 2006-04-26 |
US9675637B2 (en) | 2017-06-13 |
ES2294543T3 (es) | 2008-04-01 |
DE602004008927T2 (de) | 2008-06-05 |
JP2007528855A (ja) | 2007-10-18 |
US20170281673A1 (en) | 2017-10-05 |
EP1653978A1 (de) | 2006-05-10 |
EP1653978B1 (de) | 2020-06-03 |
CA2536827A1 (en) | 2005-01-20 |
US20100247682A1 (en) | 2010-09-30 |
US20070154569A1 (en) | 2007-07-05 |
AU2004255268B2 (en) | 2010-04-01 |
JP5564157B2 (ja) | 2014-07-30 |
US9700578B2 (en) | 2017-07-11 |
AU2004257693A1 (en) | 2005-01-27 |
US20150125553A1 (en) | 2015-05-07 |
CA2536827C (en) | 2014-09-16 |
DE602004008927D1 (de) | 2007-10-25 |
AU2004255268A1 (en) | 2005-01-20 |
US20120195983A1 (en) | 2012-08-02 |
US9387224B2 (en) | 2016-07-12 |
US8927030B2 (en) | 2015-01-06 |
EP1648475B1 (de) | 2007-09-12 |
WO2005004884A2 (en) | 2005-01-20 |
JP2012092129A (ja) | 2012-05-17 |
WO2005007173A1 (en) | 2005-01-27 |
JP5564158B2 (ja) | 2014-07-30 |
AU2004257693B2 (en) | 2009-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE372777T1 (de) | Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen | |
Zurita et al. | The pig model of chronic paraplegia: a challenge for experimental studies in spinal cord injury | |
ATE355852T1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
DE60137635D1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
JP2004532215A (ja) | 睡眠時の自律的安定性に関するカンナビノイドの機能的役割 | |
Staszelis et al. | The effect of ketamine on delta-range coupling between prefrontal cortex and hippocampus supported by respiratory rhythmic input from the olfactory bulb | |
Velmahos et al. | Physiologic monitoring of circulatory dysfunction in patients with severe head injuries | |
RU2230521C2 (ru) | Способ формирования большой затылочной цистерны при синдроме арнольд-киари | |
RU2133629C1 (ru) | Способ уменьшения хронической гипоксии тканей | |
RU2414173C1 (ru) | Способ лечения субдуральной гематомы | |
ABAKUMOW et al. | Initial depression and normalization of higher extremity oxygenation in an autistic girl due to kinesitherapy using an adapted high altitude protection suit: a case study | |
RU2248818C1 (ru) | Способ лечения подростков с гипоталамическим синдромом пубертатного периода | |
Gehlot et al. | Valsalva Manoeuvre: A Versatile Diagnostic and Therapeutic Method | |
RU2178288C2 (ru) | Способ лечения заболеваний нервной системы | |
RU2232014C1 (ru) | Способ лечения сенсоневральной тугоухости | |
Bloch et al. | Teratoma of the conus medullaris | |
Dias et al. | Effects of jugular vein occlusion on cardiovascular parameters in horses during exercise on a treadmill | |
RU2604819C1 (ru) | Способ лечения церебральной ишемии новорожденных | |
RU2632619C1 (ru) | Способ лечения больных артериальной гипертонией | |
Mate et al. | Monitoring distal limb perfusion using near-infrared spectroscopy in patients on intra-aortic balloon pump | |
RU2481131C1 (ru) | Способ лечения гипоталамического синдрома пубертатного периода | |
RU2019209C1 (ru) | Способ лечения синдрома длительного сдавления | |
UA39913U (uk) | Спосіб мініінвазивного хірургічного лікування кіст підшлункової залози із застосуванням озоноквантової терапії | |
PT1455772E (pt) | Remédio para o tratamento radical de tumores, de processos inflamatórios, infecções fúngicas e outras alterações dos tecidos, diagnóstico e profilaxia, e método e sua aplicação | |
CN107793404A (zh) | 一种治疗缺血性脑损伤药物组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1648475 Country of ref document: EP |